復旦張江(688505.SH)業績快報:2021年度淨利升29.53%至2.13億元
格隆匯2月25日丨復旦張江(688505.SH)披露2021年度業績快報,報吿期內,公司實現營業總收入11.40億元,同比增長36.76%;歸屬於母公司所有者的淨利潤2.13億元,同比增長29.53%;歸屬於母公司所有者的扣除非經常性損益的淨利潤1.73億元,同比增長35.96%;基本每股收益0.21元。
報吿期內,隨着國內疫情得到有效控制,藥品流通及醫院患者就診顯著恢復,集團各醫藥產品的出貨量及藥品終端使用量亦穩步恢復,公司藥品銷售情況好轉。公司營業收入同比增長36.76%,其他相關經營數據相應增長。
為建立、健全公司長效激勵約束機制,吸引和留住公司管理人員、核心技術人員以及其他人員,充分調動其積極性和創造性,公司於報吿期內實施《2021年限制性股票激勵計劃》,2021年確認股份支付相關費用合計6497.37萬元。
若剔除上述股份支付費用的影響,公司2021年實現歸屬於母公司所有者的淨利潤同比增長68.99%,2021年歸屬於母公司所有者的扣除非經常性損益的淨利潤同比增長86.97%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.